An overview of the status of acellular pertussis vaccines in practice

Anna Lena Lopez, Dean A Blumberg

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Infection with Bordetella pertussis continues to result in widespread morbidity and mortality. Although whole cell pertussis vaccines are effective in controlling pertussis, concerns relating to adverse effects following vaccination have led to the development of a new generation of pertussis vaccines. Acellular pertussis vaccines have decreased endotoxin content and are less reactogenic than whole cell vaccines. The composition of acellular pertussis vaccines varies, resulting in differing immunogenicity. Recent studies have demonstrated that these vaccines, in general, have an efficacy similar to that of whole cell vaccines. The development of acellular pertussis vaccines is an advance that should result in less discomfort from vaccination and the potential for increased vaccine usage, resulting in the possible elimination of this disease.

Original languageEnglish (US)
Pages (from-to)189-196
Number of pages8
JournalDrugs
Volume54
Issue number2
StatePublished - 1997

Fingerprint

Acellular Vaccines
Pertussis Vaccine
Vaccines
Vaccination
Disease Eradication
Bordetella pertussis
Whooping Cough
Endotoxins
Morbidity
Mortality
Infection
Chemical analysis

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

An overview of the status of acellular pertussis vaccines in practice. / Lopez, Anna Lena; Blumberg, Dean A.

In: Drugs, Vol. 54, No. 2, 1997, p. 189-196.

Research output: Contribution to journalArticle

Lopez, Anna Lena ; Blumberg, Dean A. / An overview of the status of acellular pertussis vaccines in practice. In: Drugs. 1997 ; Vol. 54, No. 2. pp. 189-196.
@article{f8b4171d53364783973712e400e5a4f7,
title = "An overview of the status of acellular pertussis vaccines in practice",
abstract = "Infection with Bordetella pertussis continues to result in widespread morbidity and mortality. Although whole cell pertussis vaccines are effective in controlling pertussis, concerns relating to adverse effects following vaccination have led to the development of a new generation of pertussis vaccines. Acellular pertussis vaccines have decreased endotoxin content and are less reactogenic than whole cell vaccines. The composition of acellular pertussis vaccines varies, resulting in differing immunogenicity. Recent studies have demonstrated that these vaccines, in general, have an efficacy similar to that of whole cell vaccines. The development of acellular pertussis vaccines is an advance that should result in less discomfort from vaccination and the potential for increased vaccine usage, resulting in the possible elimination of this disease.",
author = "Lopez, {Anna Lena} and Blumberg, {Dean A}",
year = "1997",
language = "English (US)",
volume = "54",
pages = "189--196",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",
number = "2",

}

TY - JOUR

T1 - An overview of the status of acellular pertussis vaccines in practice

AU - Lopez, Anna Lena

AU - Blumberg, Dean A

PY - 1997

Y1 - 1997

N2 - Infection with Bordetella pertussis continues to result in widespread morbidity and mortality. Although whole cell pertussis vaccines are effective in controlling pertussis, concerns relating to adverse effects following vaccination have led to the development of a new generation of pertussis vaccines. Acellular pertussis vaccines have decreased endotoxin content and are less reactogenic than whole cell vaccines. The composition of acellular pertussis vaccines varies, resulting in differing immunogenicity. Recent studies have demonstrated that these vaccines, in general, have an efficacy similar to that of whole cell vaccines. The development of acellular pertussis vaccines is an advance that should result in less discomfort from vaccination and the potential for increased vaccine usage, resulting in the possible elimination of this disease.

AB - Infection with Bordetella pertussis continues to result in widespread morbidity and mortality. Although whole cell pertussis vaccines are effective in controlling pertussis, concerns relating to adverse effects following vaccination have led to the development of a new generation of pertussis vaccines. Acellular pertussis vaccines have decreased endotoxin content and are less reactogenic than whole cell vaccines. The composition of acellular pertussis vaccines varies, resulting in differing immunogenicity. Recent studies have demonstrated that these vaccines, in general, have an efficacy similar to that of whole cell vaccines. The development of acellular pertussis vaccines is an advance that should result in less discomfort from vaccination and the potential for increased vaccine usage, resulting in the possible elimination of this disease.

UR - http://www.scopus.com/inward/record.url?scp=0030810892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030810892&partnerID=8YFLogxK

M3 - Article

C2 - 9257078

AN - SCOPUS:0030810892

VL - 54

SP - 189

EP - 196

JO - Drugs

JF - Drugs

SN - 0012-6667

IS - 2

ER -